Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-25 @ 4:21 PM
NCT ID:
NCT01905657
Group ID:
EG003
Title:
Pembrolizumab 2 mg/kg First Course to Pembrolizumab 200 mg Second Course
Description:
Qualified participants who received the first course of pembrolizumab 2 mg/kg Q3W for up to 2 years, but experienced disease progression, initiated a second course of pembrolizumab at the investigator's discretion, at 200 mg IV Q3W for up to 1 year.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
14
Other Number Affected:
9
Other Number At Risk:
14
Study:
NCT01905657
Results Section:
NCT01905657
Adverse Events Module:
NCT01905657